1. Home
  2. PBYI vs PLG Comparison

PBYI vs PLG Comparison

Compare PBYI & PLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • PLG
  • Stock Information
  • Founded
  • PBYI 2010
  • PLG 2000
  • Country
  • PBYI United States
  • PLG Canada
  • Employees
  • PBYI N/A
  • PLG N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • PLG
  • Sector
  • PBYI Health Care
  • PLG
  • Exchange
  • PBYI Nasdaq
  • PLG Nasdaq
  • Market Cap
  • PBYI 154.1M
  • PLG 133.6M
  • IPO Year
  • PBYI N/A
  • PLG N/A
  • Fundamental
  • Price
  • PBYI $3.14
  • PLG $1.20
  • Analyst Decision
  • PBYI Strong Buy
  • PLG
  • Analyst Count
  • PBYI 1
  • PLG 0
  • Target Price
  • PBYI $7.00
  • PLG N/A
  • AVG Volume (30 Days)
  • PBYI 418.2K
  • PLG 521.8K
  • Earning Date
  • PBYI 05-01-2025
  • PLG 04-14-2025
  • Dividend Yield
  • PBYI N/A
  • PLG N/A
  • EPS Growth
  • PBYI 37.78
  • PLG N/A
  • EPS
  • PBYI 0.62
  • PLG N/A
  • Revenue
  • PBYI $230,468,000.00
  • PLG N/A
  • Revenue This Year
  • PBYI N/A
  • PLG N/A
  • Revenue Next Year
  • PBYI $3.27
  • PLG N/A
  • P/E Ratio
  • PBYI $5.06
  • PLG N/A
  • Revenue Growth
  • PBYI N/A
  • PLG N/A
  • 52 Week Low
  • PBYI $2.23
  • PLG $1.06
  • 52 Week High
  • PBYI $6.06
  • PLG $2.27
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 45.33
  • PLG 43.22
  • Support Level
  • PBYI $3.14
  • PLG $1.23
  • Resistance Level
  • PBYI $3.56
  • PLG $1.32
  • Average True Range (ATR)
  • PBYI 0.19
  • PLG 0.07
  • MACD
  • PBYI -0.05
  • PLG 0.00
  • Stochastic Oscillator
  • PBYI 17.54
  • PLG 15.79

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About PLG Platinum Group Metals Ltd. (Canada)

Platinum Group Metals Ltd is the operator of the Waterberg Project, a bulk underground PGM deposit located in South Africa. Waterberg was discovered by Platinum Group and is being jointly developed with Implats, the Japan Oil, Gas and Metals National Corporation (JOGMEC) and Hanwa Co. Ltd. Waterberg has the potential to be a large-scale, low-cost producer of palladium, platinum, rhodium, and gold. Geographically, it operates in Canada and South Africa.

Share on Social Networks: